Description
ELORALINTIDE 5MG LY3841136
5mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
Eloralintide is an novel long-acting amylin receptor agonist currently under scientific investigation. Within controlled experimental settings, this peptide is studied for its selective engagement with amylin pathways, modulating postprandial glucose dynamics, gastric emptying rates, and central satiety signals independently of traditional incretin pathways.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | Eloralintide 5mg |
| Sequence | |
| Molecular Formula | C₂₀₁H₃₁₉N₄₉O₆₅S₂ |
| Molecular Weight | 4526.11 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 5 mg per vial |
| Storage | -20°C (Dry) / 2–8°C (Reconstituted) |
| Grade | Laboratory Research Grade |
Eloralintide 5mg Research Application Areas
Current laboratory studies on Eloralintide 5mg focus on the following key research areas:
- Selective Amylin Agonism: Investigation of high-affinity binding to amylin receptors and its influence on metabolic regulation.
- Gastric Motility Modulation: Evaluation of controlled gastric emptying rates in preclinical laboratory models.
- Glycemic Regulation: Analysis of postprandial glucagon suppression and glucose stabilization mechanisms.
- Satiety Signal pathways: Research on central nervous system pathways governing appetite modulation and energy balance.
Looking for another Eloralintide 5mg alternative? Explore our full range of Research Peptides.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
